Understanding How Ketamine Brings About Rapid Improvement in OCD

Phase 2 Active not recruiting 120 enrolled Stanford University University of Connecticut · collab

RandomizedParallel-groupQuadruple-blindTreatment

The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.

Evaluation	Drug	Modality	Dose	Route
Subject	Ketamine	Small molecule	0.5 mg/kg	Intravenous
Comparator	Midazolam	Small molecule	0.045 mg/kg	—